Evidence map›Paper›PMID 41654501›Full record

ArticleNPJ Parkinson's disease2026

Deep neurobehavioral phenotyping uncovers neural fingerprints of locomotor deficits in Parkinson's disease.

Elisa Lilly Garulli, Timon Merk, Ghadi El Hasbani, Burçe Kabaoğlu, Rafaël De Sa, Ruben Behrsing, Dennis Doll, Michael Franz-Josef Schellenberger, Ibrahem Hanafi, Arend Vogt and 7 more

Abstract read
In one paragraph

Article in NPJ Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Elisa Lilly GarulliDepartment of Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany. elisa.garulli@charite.de.
Timon MerkMovement Disorders Unit, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Ghadi El HasbaniDepartment of Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Burçe KabaoğluDepartment of Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Rafaël De SaDepartment of Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Ruben BehrsingDepartment of Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Dennis DollDepartment of Neurology, University Hospital Wuerzburg, Wuerzburg, Germany.
Michael Franz-Josef SchellenbergerDepartment of Neurology, University Hospital Wuerzburg, Wuerzburg, Germany.
Ibrahem HanafiDepartment of Neurology, University Hospital Wuerzburg, Wuerzburg, Germany.
Arend VogtDepartment of Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Wolf-Julian NeumannMovement Disorders Unit, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Chiara PalmisanoDepartment of Neurology, University Hospital Wuerzburg, Wuerzburg, Germany.
Ioannis Ugo IsaiasDepartment of Neurology, University Hospital Wuerzburg, Wuerzburg, Germany.
Yangfan PengDepartment of Neurology and Neuroscience Research Center, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Matthias EndresDepartment of Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Christoph HarmsDepartment of Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Nikolaus WengerDepartment of Experimental Neurology, Charité - Universitätsmedizin Berlin, Berlin, Germany. nikolaus.wenger@charite.de.

Funding

Deutsche Forschungsgemeinschaft TRR 295-424778381Deutsches Zentrum für Herz-Kreislaufforschung FKZ81X2100285DRFZ KFO BeCAUSE-Y EN343/16-1European Research Council 101077060Fondation Leducq 17CDV03Volkswagen Foundation Freigeist Project
6 · The paper itself

Abstract

Gait deficits present an unresolved therapeutic challenge in Parkinson's disease. At the behavioral level, symptoms exhibit heterogeneity, including bradykinesia and hypokinesia during cyclical limb movements, and sudden, involuntary interruptions in the gait sequence, known as freezing of gait. The neural activities driving these various deficits remain largely unknown. Here, we investigated the neural correlates of gait sequence interruptions with a deep phenotyping approach. For this, we transformed kinematic trajectories and cortical oscillations into continuous time series of neurobehavioral features. Next, we combined low-dimensional embedding with supervised classification to identify cortical oscillation features that drive gait deficits. In a rodent Parkinson's disease model, our approach revealed that gait, akinesia, and stationary movements occupy distinct regions in the low-dimensional embedding space. Among the predominant features separating the states, Hjorth complexity and mobility modulated at akinesia onset. Additionally, we validated our findings in two Parkinson's patients with freezing of gait, where neural features in STN recordings partially reflected the results in rodents. The presented neurobehavioral phenotyping approach is translational and can easily be generalized to the analysis of other complex movement disorders. Together, our results highlight specific neural features as potential biomarkers that may support the development of adaptive closed-loop algorithms for gait therapy in PD.

Identifiers

PMID41654501
PMCPMC12992695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.